OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT January ___, 2015Underwriting Agreement • January 20th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), agrees, subject to the terms and conditions set forth herein, with each of the underwriters listed on Schedule A hereto (collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), to sell and issue to the Underwriters an aggregate of 5,750,000 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), together with 4,312,500 warrants to purchase an aggregate of 4,312,500 shares of Common Stock at an exercise price equal to $___ per share (each a “Warrant” and collectively, the “Warrants”). Each Share shall be sold together with 0.75 of a Warrant to purchase one additional share of Common Stock and the Shares and Warrants shall be separately transferable immediately upon issuance. The offering and sale of Shares and Warrants contemplated by this underwriting agreement (this “Agreement”) is referred
